期刊文献+

A polyphenol-induced hydroxyapatite coating modulates corrosion resistance and biocompatibility of magnesium alloys

原文传递
导出
摘要 In order to solve the problem of excessive degradation rate and insufficient biocom-patibility of magnesium-based bone implants,a polyphenol(EGCG)induced hydroxy-apatite(HA)coating was prepared on the surface of AZ31 alloy.The physical and chemical properties and corrosion resistance of the coating were analysed in depth,and its biocompatibility was preliminarily explored in vitro.The results showed that the polyphenol(EGCG)conversion coating constructed on the AZ31 could successfully induce the formation of HA by complexing the phenolic hydroxyl group with calcium ions.The electrochemical and long-term immersion experiments showed that the corrosion resistance of EGCG/HA composite coating was significantly improved.The self-corrosion current density,hydrogen evolution and the increase of pH value of AZ31-EGCG/HA were significantly lower than those of AZ31.On the basis of inhibiting the excessive corrosion of the substrate,the composite coating significantly improves the compatibility of pre-osteoblasts,supports the adhesion and spreading and effectively reduces the haemolysis rate to less than 5%.The preparation method of the coating is simple,low cost and suitable for complex shape surfaces,which can significantly improve the corrosion resistance and biocompatibility of the AZ31 substrate.It is expected to provide a solution for the surface modification of magnesium-based bone implants.
出处 《Biosurface and Biotribology》 EI 2023年第4期129-141,共13页 生物表面与生物摩擦学(英文)
基金 National Natural Science Foundation of China,Grant/Award Number:52101286 Natural Science Foundation of Sichuan Province,Grant/Award Number:2022NSFSC2011 National College Student Innovation and Entrepreneurship Training Program,Grant/Award Number:202211360009。
  • 相关文献

参考文献2

二级参考文献160

  • 1G.L. Song, S.Z. Song, Adv. Eng. Mater. 9 (2007) 298-302.
  • 2F. Witte, V. Kaese, H. Haferkamp, E. Switzer, A. Meyer-Lindenberg, C.J. Wirth, H. Windhagen, Biomaterials 26 (2005) 3.
  • 3J.C. Gao, S. Wu, L.Y. Qiao, Y. Wang, Trans. Nonferrous Met. Soc. China 18 (2008) 588-592.
  • 4B. Heublein, R. Rohde, V. Kaese, M. Niemeyer, W. Hartung, A. Haverich, Heart 89 (2003) 651-656.
  • 5C.D. Mario, H. Griffiths, O. Goktekin, J. Interv. Cardiol. 17 (2004) 391-395.
  • 6P. Peeters, M. Bosiers, J. Verbist, K. Deloose, B. Heublein, J. Endovascular Ther. 12 (2005) 1-5.
  • 7R. Erbel, C. Di Mario, J. Bartunek, J. Bonnier, B. de Bruyne, F.R. Eberli, P. Erne, M. Haude, B. Heublein, M. Horriga.
  • 8R. Waksman, EuroIntervention 5 (2009) FI03-FI08.
  • 9S.S.A. El-Rahman, Pharmacol. Res. 47 (2003) 189-194.
  • 10Y Nakamura, Y Tsumura, Y. Tonogai, T. Shibata, Y Ito, Toxicol. Sci. 37 (1997) 106-116.

共引文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部